INTRODUCTION: To investigate clinical, virological and immunological parameters and better understand the etiopathogenesis of AIDS-related leukoencephalopathies, a longitudinal survey was performed. RESULTS: Clinical observations and MRI examinations were performed on 160 eligible HIV+ HAART treated patients: 33 MRI+ and 45 MRI-patients were enrolled in the study, together with 27 healthy subjects (HC), as control. In addition a group of control constituted of 20 Relapsing-remitting (RR) Multiple Sclerosis (MS) patients has been enrolled. No virus was found in CSF of 12 patients, classified as possible Not Determined Leukoencephalopathy (NDLE) subjects and JCV DNA was found in CSF of 11 Progressive Multifocal Leukoencephalopathy (PML) pat...
Background/ Objectives: Due to the HAART use, the prognosis of Progressive Multifocal Leukoencephalo...
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the CNS of immu...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multi...
To investigate clinical, virological and immunological parameters and better understand the etiopath...
INTRODUCTION: The use of HAART in the treatment of HIV infection has led to a marked reduction in AI...
OBJECTIVE: HAART has changed the scenario of HIV-related neurological disorders but the incidence of...
Background: HAART has changed the AIDS scenario, but neurological disorders including PML and JC vir...
BACKGROUND: HAART has changed the scenario of HIV-related neurological disorders but the incidence o...
INTRODUCTION: After the introduction of HAART, the reduction of HIV related CNS disorders has been l...
We are performing a longitudinal survey to investigate AIDS related leukoencephalopathies, including...
Background: The introduction of highly active antiretroviral therapy (HAART) has significantly modif...
Objectives. To analyze virological and immunological features of AIDS-related progressive multifocal...
Progressive multifocal leukoencephalopathy (PML) usually is a rapid and fatal demyelinating disease ...
John Cunningham virus (JCV), the etiological agent of progressive multifocal leukoencephalopathy (PM...
Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain ca...
Background/ Objectives: Due to the HAART use, the prognosis of Progressive Multifocal Leukoencephalo...
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the CNS of immu...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multi...
To investigate clinical, virological and immunological parameters and better understand the etiopath...
INTRODUCTION: The use of HAART in the treatment of HIV infection has led to a marked reduction in AI...
OBJECTIVE: HAART has changed the scenario of HIV-related neurological disorders but the incidence of...
Background: HAART has changed the AIDS scenario, but neurological disorders including PML and JC vir...
BACKGROUND: HAART has changed the scenario of HIV-related neurological disorders but the incidence o...
INTRODUCTION: After the introduction of HAART, the reduction of HIV related CNS disorders has been l...
We are performing a longitudinal survey to investigate AIDS related leukoencephalopathies, including...
Background: The introduction of highly active antiretroviral therapy (HAART) has significantly modif...
Objectives. To analyze virological and immunological features of AIDS-related progressive multifocal...
Progressive multifocal leukoencephalopathy (PML) usually is a rapid and fatal demyelinating disease ...
John Cunningham virus (JCV), the etiological agent of progressive multifocal leukoencephalopathy (PM...
Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain ca...
Background/ Objectives: Due to the HAART use, the prognosis of Progressive Multifocal Leukoencephalo...
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the CNS of immu...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multi...